PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Mark J. McKeage, Michael B. Jameson, Ramesh K. Ramanathan, Joseph Rajendran, Yongchuan Gu, William R. Wilson, Teresa J. Melink, N. S. Tchekmedyian

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences